A detailed history of Van Strum & Towne Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Van Strum & Towne Inc. holds 4,675 shares of LLY stock, worth $3.74 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares
4,675
Previous 5,275 11.37%
Holding current value
$3.74 Million
Previous $4.78 Million 13.28%
% of portfolio
1.44%
Previous 1.74%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$772.14 - $960.02 $463,284 - $576,012
-600 Reduced 11.37%
4,675 $4.14 Million
Q2 2024

Jul 25, 2024

SELL
$724.87 - $909.04 $144,974 - $181,808
-200 Reduced 3.65%
5,275 $4.78 Million
Q4 2022

Feb 01, 2023

BUY
$321.55 - $374.67 $24,116 - $28,100
75 Added 1.39%
5,475 $2 Million
Q4 2020

Feb 03, 2021

BUY
$130.46 - $172.63 $704,484 - $932,202
5,400 New
5,400 $912,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $760B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Van Strum & Towne Inc. Portfolio

Follow Van Strum & Towne Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Strum & Towne Inc., based on Form 13F filings with the SEC.

News

Stay updated on Van Strum & Towne Inc. with notifications on news.